Oncology | Karger

⚠️This account isn’t being managed anymore. Follow @ResearchKarger for all Karger #Oncology news and publications.

[Oncology | Karger @OncoKarger]

⚠️This account will no longer be active as of July 1, 2024! To stay up-to-date with all Karger #Oncology news and publications, follow @ResearchKarger.

[Karger Publishers @KargerPublisher]

📢 We’re thrilled to announce an exciting new partnership with @ByLudenso, aimed at revolutionizing scientific journal content.

By integrating #AugmentedReality (AR) technology, Karger #journals will now offer #authors innovative ways to visualize their #research.

More in the latest #PressRelease 🔗 https://t.co/euzuTkvqVf

[Oncology | Karger @OncoKarger]

Heading to #ASCO24?
Make sure to swing by the Karger booth no. 37019 for a great experience! Discover latest research in #Oncology and exciting #CallsForPapers opportunities. Our team is eager to connect and engage with you!

ℹ️ https://t.co/liKnLxCUkj

@ASCO

[Oncology | Karger @OncoKarger]

🌟 Join us at #ASCO24, @ASCO! 🌟
Meet Us at Booth no. 37019 and dive into the latest publications while enjoying a special congress discount. Discover latest research in #Oncology and learn about our #CallsForPapers. See you in Chicago! 👋

🔗 https://t.co/DQ1UcJMS5c

[Oncology | Karger @OncoKarger]

Tomorrow! Join us for this thought-provoking #panel discussion aiming to critically examine whether #OpenAccess, despite its advancements, is only halfway towards achieving its goals.

Register here 🔗 https://t.co/EKGsELf7c9

[Oncology | Karger @OncoKarger]

📣 #CallforPapers in #OncolResTreat
📅 May 31
🔛 Role of Sex and Gender in Oncology
🔗 https://t.co/MWguYn5R45
👨‍🏫 @heinrich_kat, Marie von Lilienfeld-Toal
Contribute to clinical and research questions addressing the impact of sex and gender in cancer diagnosis and treatment.

[Oncology | Karger @OncoKarger]

🌟 Exciting News for Nurses! 🏥 Introducing our New Course: "Fast Facts: Biosimilars & Chemo-Induced Neutropenia" 💉📘

💪💊 Elevate your expertise in patient care.

Enroll now: https://t.co/BEjcH2Gm9w

#CME #NursingEd #Biosimilars #Neutropenia #KargerPublishers

[Oncology | Karger @OncoKarger]

📢 The newest issue of Oncology 2024, Vol. 102, No. 2 is now released!

Check it out here ➡️ https://t.co/hSZT4ctpga

Topics in this issue include: #Metastasis #ColorectalCancer #BreastCancer #NeoadjuvantTherapy #GastrointestinalCancer #Biomarker

[Oncology | Karger @OncoKarger]

🚀 Exciting News! Unveiling our New Course: "Biosimilars in Chemotherapy Induced Neutropenia - What, Why, How"

🌐 Dive deep into biosimilars, high-risk regimens, and clinical & economic considerations.

Enroll Now: https://t.co/Vas32lXxI3💡
#CME #Biosimilars #Courses

[Oncology | Karger @OncoKarger]

Which Patients Need #Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of #EndocrineResponse

➡️ https://t.co/HlZ3OCM0Ib
✍️ Schmidt M.
📖 #BreastCare

#OpenAcces #ReviewArticle

[Oncology | Karger @OncoKarger]

📢 The newest issue of Oncology 2023, Vol. 101, No. 12 is now released!

Check it out here ➡️ https://t.co/3x9Wo4sY8h

Topics in this issue include: #BreastCancer #TeratomaSyndrome #Anamorelin #GastricCancer #Nilotinib #Pembrolizumab #Chemotherapy #OvarianCancer

[Oncology | Karger @OncoKarger]

📚 Editor's Choice: Medical #OncologyEducation in Europe: Equipping #MedicalOncologists to Provide the #BestCare for Patients with #Cancer

➡️ https://t.co/9QLRubAdHa
✍️ Jordan J. et al.
📖 #OncolResTreat

#ReviewArticle

[Oncology | Karger @OncoKarger]

Patients with Non-Muscle-Invasive #BladderCancer Previously Treated with #Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy

➡️ https://t.co/aXkK5Ocw6x
✍️ Maeyama R. et al.
📖 #Chemotherapy

#OpenAcces

[Oncology | Karger @OncoKarger]

As we embark on the journey of discovery and innovation in 2024, may it be a year filled with groundbreaking research and advancements in medical science. We wish all our followers a Happy New Year filled with new opportunities. Happy New Year! 🌟

🥂 #NewYear2024

[Oncology | Karger @OncoKarger]

📢 The newest issue of Breast Care 2023, Vol. 18, No. 6 is now released!

Check it out here ➡️ https://t.co/zaIH2hS89w

Topics in this issue include: #Chemotherapy #Radiotherapy #EndocrineTherapy #BreastCancer #LocoregionalTherapy

[Oncology | Karger @OncoKarger]

May the spirit of the season bring you happiness and peace. Wishing you a joyful holiday season filled with warmth and togetherness. 🌟🎄

#SeasonsGreetings #HappyHolidays

[Oncology | Karger @OncoKarger]

📢 The newest issue of Chemotherapy 2023, Vol. 68, No. 4 is now released!

Check it out here ➡️ https://t.co/c48KrjfRuu

Topics in this issue include: #Metformin #BladderCancer #GastricCancer #ColonCancer #HodgkinLymphoma

[USC Urology @USC_Urology]

Radiogenomic correlations with ccRCC biomarkers
🧬Use of TCGA-KIRC & TCIA-KIRC databases
📈After stratification: predictions of KDM5C, SETD2, PBRM1, & mTOR mutation status showed significant improvements AUC 0.70-0.86
#Radiogenomics @OncoKarger https://t.co/77W5U2Lu2n

[Oncology | Karger @OncoKarger]

Non-Surgical Site Pain in Women following #BreastCancer Surgery: A #SystematicReview and #MetaAnalysis

➡️ https://t.co/hlGgbOZQpP
✍️ Burton G. et al.
📖 #BreastCare

#OpenAcces

[Oncology | Karger @OncoKarger]

The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell #LungCancer

➡️ https://t.co/onlCjG7YlF
✍️ Igawa S. et al.
📖 #Oncology

#ResearArticle #OpenAccess #SCLC